Can early heart support save newborn brains? a new trial aims to find out.
NCT ID NCT07406477
First seen Feb 13, 2026 · Last updated May 24, 2026 · Updated 17 times
Summary
This study tests whether giving a heart medication called dobutamine early, before signs of heart failure appear, is safe and possible in newborns with HIE who are already receiving cooling therapy. Forty babies will be randomly assigned to receive either the medication or a placebo. The goal is to see if early heart support can improve blood flow to the brain and other organs, potentially reducing injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXIC-ISCHEMIC ENCEPHALOPATHY (HIE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Alexandra Hospital
Edmonton, Alberta, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.